JP Morgan Chase’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-744,968
Closed -$11.7M 7165
2022
Q2
$11.7M Buy
744,968
+173,027
+30% +$2.64M ﹤0.01% 2022
2022
Q1
$8.7M Buy
571,941
+391,563
+217% +$5.96M ﹤0.01% 2512
2021
Q4
$2.77M Buy
180,378
+129,875
+257% +$1.71M ﹤0.01% 3572
2021
Q3
$440K Sell
50,503
-49,492
-49% -$451K ﹤0.01% 4804
2021
Q2
$1.02M Sell
99,995
-865,552
-90% -$9.14M ﹤0.01% 4272
2021
Q1
$11.5M Sell
965,547
-194,979
-17% -$2.21M ﹤0.01% 2235
2020
Q4
$10.6M Buy
1,160,526
+17,006
+1% +$132K ﹤0.01% 2173
2020
Q3
$7.02M Buy
1,143,520
+907,288
+384% +$6.92M ﹤0.01% 2304
2020
Q2
$2.1M Sell
236,232
-1,256,078
-84% -$10.8M ﹤0.01% 3075
2020
Q1
$10.8M Sell
1,492,310
-830,705
-36% -$6.16M ﹤0.01% 1681
2019
Q4
$20.5M Buy
2,323,015
+1,614,282
+228% +$12.1M ﹤0.01% 1575
2019
Q3
$4.32M Buy
708,733
+14,948
+2% +$84K ﹤0.01% 2822
2019
Q2
$2.94M Sell
693,785
-268,405
-28% -$1.42M ﹤0.01% 3104
2019
Q1
$6.05M Buy
962,190
+554,494
+136% +$3.88M ﹤0.01% 2443
2018
Q4
$2.64M Buy
407,696
+255,014
+167% +$1.95M ﹤0.01% 3088
2018
Q3
$1.27M Buy
152,682
+141,581
+1,275% +$1.08M ﹤0.01% 3767
2018
Q2
$69K Sell
11,101
-46,594
-81% -$296K ﹤0.01% 4965
2018
Q1
$395K Buy
57,695
+47,836
+485% +$304K ﹤0.01% 4113
2017
Q4
$65K Buy
+9,859
New +$60.2K ﹤0.01% 4812
2017
Q3
Sell
-1,685
Closed -$13K 5272
2017
Q2
$13K Sell
1,685
-46,321
-96% -$391K ﹤0.01% 4618
2017
Q1
$433K Sell
48,006
-83,174
-63% -$867K ﹤0.01% 3777
2016
Q4
$1.42M Sell
131,180
-1,320
-1% -$17.6K ﹤0.01% 3272
2016
Q3
$2.17M Buy
132,500
+1,400
+1% +$19.7K ﹤0.01% 2755
2016
Q2
$1.25M Buy
131,100
+2,170
+2% +$23.6K ﹤0.01% 3066
2016
Q1
$1.81M Buy
+128,930
New +$1.33M ﹤0.01% 2751
2013
Q4
Sell
-11,771
Closed -$87K 4291
2013
Q3
$87K Buy
+11,771
New +$91.6K ﹤0.01% 4204

Other funds holding NPTN

JP Morgan Chase's NPTN Position: Q3 2022 in Review

JP Morgan Chase sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 744,968 shares — an estimated $11.7M sold.

JP Morgan Chase first reported a position in NPTN in Q3 2013 and held it in 26 quarters. The position peaked at $20.5M in Q4 2019. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • JP Morgan Chase reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • JP Morgan Chase sold 744,968 NEOPHOTONICS CORP shares in Q3 2022, an estimated $11.7M.
  • JP Morgan Chase first reported a position in NEOPHOTONICS CORP in Q3 2013 and held it in 26 quarters.
  • JP Morgan Chase's NEOPHOTONICS CORP position peaked at $20.5M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.